Menlo Therapeutics Inc. (32) | Uncategorized (7)

Recent Contracts

Offer Letter, dated as of April 7, 2021, by and between Mutya Harsch and VYNE Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
Offer Letter, dated as of April 7, 2021, by and between Andrew Saik and VYNE Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 4, 2021)
Offer Letter, dated as of March 25, 2020, by and between Menlo Therapeutics Inc. and David Domzalski (Filed With SEC on May 11, 2020)
Offer Letter, dated as of March 20, 2020, by and between Menlo Therapeutics Inc. and Andrew Saik (Filed With SEC on May 11, 2020)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 3, 2020)
Form of CSR Agreement (Filed With SEC on November 12, 2019)